Assessment of the Effect of Timing of Insulin Glargine Administration (Bedtime versus Morning) on Glycemic Control in Children with Type 1 Diabetes in Cairo, Egypt: A Single Centre Experience
- 1 May 2023
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 19 (4) , 1
Abstract
Background: Diabetes control without developing hypoglycemia is challenging in Type 1 diabetes (T1D) management, with few studies evaluating the effect of insulin glargine timing on glucoregulation. Objectives: The aim is to compare glycemic control using continuous glucose monitoring (CGM) in children with T1D receiving bedtime versus morning glargine and to assess CGM effect on glycemia. Methods: This cross-sectional observational study was conducted on 30 pediatric patients with T1D receiving glargine (19 at bedtime and 11 in the morning). CGM sensor was applied for 3-5 days using the I-Pro2 blood glucose sensor. Results: Total daily dose of glargine showed a significant correlation with HbA1C (p=0.006) and percentage of glucose readings within average (p=0.039). HbA1C correlated significantly with time in range (TIR) (p=0.049). Nocturnal hypoglycemia was significantly higher in the bedtime glargine group than in the morning one (p=0.016). The morning glargine group showed better control in terms of lower HbA1C and higher TIR, but these did not reach statistical significance. Follow- up after 3 months revealed significant improvement in the percentage of hyperglycemia, BG readings within average, as well as HbA1c (p:0.001). Conclusions: Bedtime glargine administration was associated with a higher frequency of occurrence of nocturnal hypoglycemia. No statistically significant difference in glycemic control between both groups was found. CGM use improved glycemic control.Keywords
This publication has 20 references indexed in Scilit:
- Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic OutcomesDiabetes Technology & Therapeutics, 2017
- 6. Glycemic TargetsDiabetes Care, 2016
- The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot StudyDiabetes Therapy, 2015
- Pharmacokinetics and Pharmacodynamics of Insulin Glargine Given in the Evening as Compared With in the Morning in Type 2 DiabetesDiabetes Care, 2014
- Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groupsIndian Journal of Endocrinology and Metabolism, 2014
- Continuous glucose monitoring systems for type 1 diabetes mellitusCochrane Database of Systematic Reviews, 2012
- Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care SystemsDiabetes Care, 2011
- A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 DiabetesJournal of Clinical Research in Pediatric Endocrinology, 2011
- Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 DiabetesDiabetes Care, 2005
- A Randomized Clinical Trial Comparing Breakfast, Dinner, or Bedtime Administration of Insulin Glargine in Patients With Type 1 DiabetesDiabetes Care, 2003